Die Übersetzung dieser Seite ist experimentell und in Entwicklung. Wir freuen uns über Ihr !

Salesforce Zukünftiges Wachstum

Future Kriterienprüfungen 2/6

Salesforce wird ein jährliches Gewinn- und Umsatzwachstum von 18.7% bzw. 9% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 18.3% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 17.3% betragen.

Wichtige Informationen

13.7%

Wachstumsrate der Gewinne

12.7%

EPS-Wachstumsrate

Software Gewinnwachstum15.7%
Wachstumsrate der Einnahmen8.6%
Zukünftige Eigenkapitalrendite16.0%
Analystenabdeckung

Good

Zuletzt aktualisiert10 Jun 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

Salesforce: Company Has Become A Show Me Story

Jun 04

Salesforce Q1 Earnings Preview: Watch For Acceleration In The Data Cloud

May 28

At US$284, Is It Time To Put Salesforce, Inc. (NYSE:CRM) On Your Watch List?

May 22
At US$284, Is It Time To Put Salesforce, Inc. (NYSE:CRM) On Your Watch List?

Salesforce Stock: Dividends Provide Valuation Clarity

May 20

Investor Optimism Abounds Salesforce, Inc. (NYSE:CRM) But Growth Is Lacking

May 05
Investor Optimism Abounds Salesforce, Inc. (NYSE:CRM) But Growth Is Lacking

Salesforce: Improving Profitability And Robust Cash Flows

May 02

Salesforce: On Track To Deliver Solid Revenue Growth

Apr 23

Does Salesforce (NYSE:CRM) Have A Healthy Balance Sheet?

Apr 15
Does Salesforce (NYSE:CRM) Have A Healthy Balance Sheet?

Salesforce: Assessing Potential Informatica Acquisition Impact On Bullish Thesis

Apr 14

Salesforce: Too Far, Too Fast (Rating Downgrade)

Apr 02

Salesforce: Currently Overvalued And It Requires A Lot To Revert It (Downgrading To Hold)

Mar 23

Salesforce: Outlook For This AI Stock After Recent Downsizing

Mar 14

Salesforce: Einstein Can Be Trusted, Thanks To Data Cloud

Mar 02

If You Can Predict Cash Flow You Can Predict Stock Price - Austin Hankwitz

Feb 22

Salesforce: Valuation Risk Might Be Offset By Einstein AI

Feb 16

Why Salesforce, Inc. (NYSE:CRM) Could Be Worth Watching

Jan 29
Why Salesforce, Inc. (NYSE:CRM) Could Be Worth Watching

Salesforce: Net Cash, Share Repurchases, Growing Margins, GARP Valuation

Jan 26

Salesforce's Evolution Into AI And Focus On Profitability Make It A Long-Term Investment Opportunity

Jan 18

Is Salesforce (NYSE:CRM) Using Too Much Debt?

Jan 15
Is Salesforce (NYSE:CRM) Using Too Much Debt?

Getting In Cheap On Salesforce, Inc. (NYSE:CRM) Is Unlikely

Dec 28
Getting In Cheap On Salesforce, Inc. (NYSE:CRM) Is Unlikely

Salesforce: Remains Well-Positioned For Further Upside

Dec 26

After A 27% Rally, Salesforce Still Has A Lot Of Room For Upside

Dec 13

Salesforce Q3: Crushing It With FCF, Buybacks, And Raised Outlook

Dec 05

Salesforce: What To Expect From Q3 FY2024 Earnings Report

Nov 27

The Issue Preventing Me From Going All In On Salesforce (Earnings Preview)

Nov 21

Salesforce, Inc. (NYSE:CRM) Shares Could Be 37% Below Their Intrinsic Value Estimate

Nov 15
Salesforce, Inc. (NYSE:CRM) Shares Could Be 37% Below Their Intrinsic Value Estimate

Salesforce: On A Path To Become The 'Most Profitable Software Company In The World'

Oct 20

Why Salesforce, Inc. (NYSE:CRM) Could Be Worth Watching

Oct 18
Why Salesforce, Inc. (NYSE:CRM) Could Be Worth Watching

These 4 Measures Indicate That Salesforce (NYSE:CRM) Is Using Debt Safely

Oct 04
These 4 Measures Indicate That Salesforce (NYSE:CRM) Is Using Debt Safely

Salesforce Could Start A Surging Run From Here - Add Before It Takes Off

Sep 29

Salesforce Is A Tr(AI)lblazer, Catch It While You Can

Sep 19

Salesforce's AI Conundrum

Sep 08

Salesforce Q2 Earning Preview: Revenue Grows Uncertain, Margin Narrative Remains Intact

Aug 27

Salesforce: Generative AI, Rising Profit Margins, Share Repurchases To Boost Stock

Aug 13

Gewinn- und Umsatzwachstumsprognosen

NYSE:CRM - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (USD Millions)
DatumUmsatzGewinneFreier CashflowBargeld aus operativen TätigkeitenDurchschn. Anz. Analysten
1/31/202745,3628,49614,71315,35422
1/31/202641,3797,15513,30214,25650
1/31/202537,8526,04311,74712,40949
4/30/202435,7435,47011,33411,990N/A
1/31/202434,8574,1369,49810,234N/A
10/31/202333,9542,5928,8129,619N/A
7/31/202333,0711,5787,5618,400N/A
4/30/202332,1883797,0647,926N/A
1/31/202331,3522086,3137,111N/A
10/31/202230,2942785,5586,305N/A
7/31/202229,3205365,6816,396N/A
4/30/202227,9401,0035,7236,448N/A
1/31/202226,4921,4445,2836,000N/A
10/31/202124,9831,7395,4936,192N/A
7/31/202123,5392,3525,4706,127N/A
4/30/202122,3504,4425,6126,170N/A
1/31/202121,2524,0724,0914,801N/A
10/31/202020,2863,5573,5624,259N/A
7/31/202019,3802,3673,4754,218N/A
4/30/202018,226-1673,4184,225N/A
1/31/202017,0981263,6884,331N/A
10/31/201915,8507363,3564,030N/A
7/31/201914,7299503,2353,875N/A
4/30/201914,0131,1583,2653,897N/A
1/31/201913,2821,1102,8033,398N/A
10/31/201812,5449542,5533,119N/A
7/31/201811,8539562,5603,101N/A
4/30/201811,1497032,4752,974N/A
1/31/201810,540360N/A2,738N/A
10/31/20179,969103N/A2,392N/A
7/31/20179,413-42N/A2,421N/A
4/30/20178,872142N/A2,341N/A
1/31/20178,437323N/A2,162N/A
10/31/20167,907206N/A1,926N/A
7/31/20167,475218N/A1,934N/A
4/30/20167,073-13N/A1,988N/A
1/31/20166,667-47N/A1,672N/A
10/31/20156,302-88N/A1,534N/A
7/31/20155,974-101N/A1,494N/A
4/30/20155,658-162N/A1,436N/A
1/31/20155,374-263N/A1,181N/A
10/31/20145,074-314N/A1,113N/A
7/31/20144,767-399N/A1,128N/A
4/30/20144,405-261N/A1,065N/A
1/31/20144,071-232N/A875N/A
10/31/20133,760-136N/A886N/A
7/31/20133,473-232N/A854N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: CRMDas prognostizierte Gewinnwachstum (18.7% pro Jahr) liegt über der Sparquote (2.4%).

Ertrag vs. Markt: CRMDie Erträge des Unternehmens (14.2% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (14.7% pro Jahr).

Hohe Wachstumserträge: CRMDie Erträge des Unternehmens werden voraussichtlich steigen, jedoch nicht deutlich.

Einnahmen vs. Markt: CRMDie Einnahmen des Unternehmens (8.6% pro Jahr) werden voraussichtlich schneller wachsen als der Markt US (8.5% pro Jahr).

Hohe Wachstumseinnahmen: CRMDie Einnahmen des Unternehmens (9% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.


Wachstumsprognosen für den Gewinn je Aktie


Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: CRMDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (17.3 %).


Wachstumsunternehmen entdecken